Pasithea Therapeutics Corp.
KTTA
$1.19
-$0.02-1.65%
| Weiss Ratings | KTTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | KTTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Very Weak | |||
| Beta / Standard Deviation | KTTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.87 | |||
| Price History | KTTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -7.75% | |||
| 30-Day Total Return | -52.21% | |||
| 60-Day Total Return | -58.10% | |||
| 90-Day Total Return | -70.54% | |||
| Year to Date Total Return | -59.39% | |||
| 1-Year Total Return | -83.47% | |||
| 2-Year Total Return | -87.89% | |||
| 3-Year Total Return | -94.73% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -86.92% | |||
| 52-Week Low % Change | 31.15% | |||
| Price | KTTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $9.25 | |||
| 52-Week Low Price | $0.92 | |||
| 52-Week Low Price (Date) | Mar 04, 2025 | |||
| 52-Week High Price (Date) | Apr 08, 2024 | |||
| Valuation | KTTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.53M | |||
| Enterprise Value | -7.83M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -14.83 | |||
| Earnings Per Share Growth | 20.74% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 0.07 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $1.19 | |||
| Enterprise Value/EBITDA (TTM) | 0.51 | |||
| Enterprise Value/EBIT | 0.49 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | KTTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 1.04M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | KTTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 702 514 4174 | |||
| Address | 1111 Lincoln Road Miami Beach, FL 33139 | |||
| Website | www.pasithea.com | |||
| Country | United States | |||
| Year Founded | 2020 | |||
| Profitability | KTTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | KTTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -40.93% | |||
| Return on Equity | -- | |||
| Income Statement | KTTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -15.49M | |||
| EBIT (TTM) | -16.14M | |||
| Net Income (TTM) | -15.78M | |||
| Net Income Avl. to Common (TTM) | -15.78M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 16.96% | |||
| EPS Diluted (TTM) | -14.83 | |||
| EPS Diluted Growth (Q YOY) | -0.05% | |||
| Balance Sheet | KTTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 9.36M | |||
| Cash Per Share (Q) | $8.97 | |||
| Total Current Assets (Q) | 9.78M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 17.81M | |||
| Current Ratio (Q) | 14.807 | |||
| Book Value Per Share (Q) | $17.05 | |||
| Total Assets (Q) | 18.64M | |||
| Total Current Liabilities (Q) | 660.40K | |||
| Total Debt (Q) | 0.00 | |||
| Total Liabilities (Q) | 824.00K | |||
| Total Common Equity (Q) | 17.81M | |||
| Cash Flow | KTTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 648.90K | |||
| Cash from Financing (TTM) | 4.54M | |||
| Net Change in Cash (TTM) | -10.22M | |||
| Levered Free Cash Flow (TTM) | -9.39M | |||
| Cash from Operations (TTM) | -15.39M | |||
